申请人:OTSUKA PHARMACEUTICAL CO., LTD.
公开号:EP0260708A2
公开(公告)日:1988-03-23
A novel cell scattering factor, i.e., tumor egress factor (hereinafter "egressin") isolated from a clone derived from a human metastatic melanoma (M3827) which possesses a loose colony morphology and from a human monocytic cell line (U-37) and processes for producing the same. Egressin is useful for the production of immunological reagents for the detection and treatment of metastatic lesions, for aiding in the transport of drugs across the blood-brain barrier, and for aiding in the control of the inflammatory response.
一种新型细胞散射因子,即肿瘤出路因子(以下简称 "出路素"),是从具有松散集落形态的人类转移性黑色素瘤(M3827)和人类单核细胞系(U-37)的克隆中分离出来的,以及生产这种因子的工艺。 出路素可用于生产检测和治疗转移性病变的免疫试剂、帮助药物通过血脑屏障以及帮助控制炎症反应。